Scientists craft custom cancer vaccine from Patient's own tumor
NCT ID NCT02950766
Summary
This early-stage study is testing the safety of a new, personalized vaccine designed to stop kidney cancer from returning after surgery. The vaccine is custom-made for each patient using unique markers from their own tumor. Researchers combine this vaccine with an approved immunotherapy drug to see if it safely trains the body's immune system to attack any remaining cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.